New Key Statistics Module, Z-Score and F-Score
NAS:VRDN Key Ratios
| Market Cap $ M | 947.79 |
| Enterprise Value $ M | 697.36 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.46 |
| Price/Sales | 2,153.57 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -5.32 |
| Beneish M-Score | -2.16 |
| 10-y EBITDA Growth Rate % | 27.00 |
| 5-y EBITDA Growth Rate % | 28.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.96 |
| EV-to-EBITDA | -2.96 |
| PEG | -- |
| Shares Outstanding M | 62.77 |
| Net Margin (%) | -75,711.47 |
| Operating Margin % | -81,035.03 |
| Pre-tax Margin (%) | -75,711.47 |
| Quick Ratio | 18.26 |
| Current Ratio | 18.26 |
| ROA % (ttm) | -59.66 |
| ROE % (ttm) | -66.52 |
| ROIC % (ttm) | -2,128.29 |
| Dividend Yield % | -- |
| Altman Z-Score | 9.21 |
| Piotroski F-Score | 3.00 |
| Positive ROA | N |
| Positive CFROA | N |
| Higher ROA y-y | Y |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | Y |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | N |
VRDN Number of Guru Trades
VRDN Volume of Guru Trades
Gurus Latest Trades with NAS:VRDN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VRDN is held by these investors
Total 1
Viridian Therapeutics Inc Insider Transactions
No Available Data
News about NAS:VRDN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers